Evidence map›Paper›PMID 23641259›Full record

ArticleTherapeutic advances in musculoskeletal disease2013

Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations.

Jeremy Sokolove, Christin M Lepus

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Therapeutic advances in musculoskeletal disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 564 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
564citing papers in PubMed, 4 pooled it
38.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03664466 nawithdrawnnot on this mapstarted 2021, after this paper: background citation

Astaxanthin Effects on Osteoarthritis Associated Pain and Inflammatory Indicators

TypeinterventionalSponsorSaint Luke's Health SystemRan2021 to 2022Enrolled0ConditionsOsteoarthritis, KneeArmsastaxanthin, Placebo
NCT05138549 phase2 / phase3terminatednot on this mapstarted 2022, after this paper: background citation

Effect of Astaxanthin for Pain, Function, and Inflammation in Patients With Advanced Osteoarthritis Awaiting Total Knee Replacement Surgery

TypeinterventionalSponsorPrisma Health-MidlandsRan2022 to 2023Enrolled16ConditionsOsteoarthritis, Knee, Osteoarthritis Knees Both, Joint InflammationArmsAstaxanthin, Placebo
3 · Its place in the literature

Who cites it

564 citing papers in PubMed, 4 syntheses or guidelines pooled it, 1,073 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Clinics in orthopedic surgery · 2025
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

504 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jeremy SokoloveDepartment of Medicine/ Immunology, VA Palo Alto Health Care System, 3801 Miranda Ave, Mail Stop 154R, Palo Alto, CA 94034 Stanford University, Palo Alto, CA, USA.
Christin M Lepus
VA Palo Alto Health Care System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) has traditionally been classified as a noninflammatory arthritis; however, the dichotomy between inflammatory and degenerative arthritis is becoming less clear with the recognition of a plethora of ongoing immune processes within the OA joint and synovium. Synovitis is defined as inflammation of the synovial membrane and is characteristic of classical inflammatory arthritidies. Increasingly recognized is the presence of synovitis in a significant proportion of patients with primary OA, and based on this observation, further studies have gone on to implicate joint inflammation and synovitis in the pathogenesis of OA. However, clinical OA is not one disease but a final common pathway secondary to many predisposing factors, most notably age, joint trauma, altered biomechanics, and obesity. How such biochemical and mechanical processes contribute to the progressive joint failure characteristic of OA is tightly linked to the interplay of joint damage, the immune response to perceived damage, and the subsequent state of chronic inflammation resulting in propagation and progression toward the phenotype recognized as clinical OA. This review will discuss a wide range of evolving data leading to our current hypotheses regarding the role of immune activation and inflammation in OA onset and progression. Although OA can affect any joint, most commonly the knee, hip, spine, and hands, this review will focus primarily on OA of the knee as this is the joint most well characterized by epidemiologic, imaging, and translational studies investigating the association of inflammation with OA.

Indexed as

inflammationinnate ImmunityOsteoarthritis

Identifiers

PMID23641259
PMCPMC3638313
OpenAlexW2082954333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.